Given the revolution in data and healthcare, Shelley Zhuang predicts how certain sectors may unfold and shares opportunities for innovation. Along the way, Shelley discusses innovations that advance precision medicine by bringing together interdisciplinary fields across biology, engineering, data science, and clinical care.
For more information on these topics, check out “Data-driven health” from 11.2 Capital.
Shelley Zhuang is the founder and managing partner at 11.2 Capital. Shelley has over 15 years of experience in technology as a software engineer, research scientist, business executive, and venture capitalist. Previously, oversaw business development and sales efforts in North America as the executive vice president of business development with Ecoplast Technologies and was actively involved in a number of investments, including Ecoplast Technologies, FeedBurner (acquired by Google for $100M), Flurry (acquired by Yahoo for $240M), PPLive (acquired by Suning for $420M), TicketsNow (acquired by Ticketmaster for $265M), Xfire (acquired by Viacom for $102M), and YeePay, as a principal at DFJ. Shelley’s a techie at heart. She’s an advisor at Skydeck and ML7 associate at Creative Destruction Lab. She also served on Enigma 2016’s program committee. Shelley holds a BS in computer science and computer engineering from the University of Missouri and a PhD in computer science from the University of California, Berkeley.
©2018, O'Reilly Media, Inc. • (800) 889-8969 or (707) 827-7019 • Monday-Friday 7:30am-5pm PT • All trademarks and registered trademarks appearing on oreilly.com are the property of their respective owners. • email@example.com